Credit Suisse’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.4M | Sell |
201,268
-16,708
| -8% | -$780K | 0.01% | 934 |
|
|
2023
Q4 | $10.4M | Sell |
217,976
-30,741
| -12% | -$1.47M | 0.01% | 901 |
|
|
2023
Q3 | $8.87M | Buy |
248,717
+40,030
| +19% | +$1.43M | 0.01% | 947 |
|
|
2023
Q2 | $9.63M | Buy |
208,687
+31,467
| +18% | +$1.45M | 0.01% | 933 |
|
|
2023
Q1 | $7.11M | Buy |
177,220
+17,900
| +11% | +$718K | 0.01% | 1082 |
|
|
2022
Q4 | $7.38M | Buy |
159,320
+18,065
| +13% | +$837K | 0.01% | 1061 |
|
|
2022
Q3 | $5.85M | Sell |
141,255
-300
| -0.2% | -$12.4K | 0.01% | 1158 |
|
|
2022
Q2 | $8.45M | Buy |
141,555
+19,128
| +16% | +$1.14M | 0.01% | 993 |
|
|
2022
Q1 | $8.89M | Buy |
122,427
+21,983
| +22% | +$1.6M | 0.01% | 1091 |
|
|
2021
Q4 | $8.45M | Buy |
100,444
+28,008
| +39% | +$2.36M | ﹤0.01% | 1204 |
|
|
2021
Q3 | $6.53M | Sell |
72,436
-20,332
| -22% | -$1.83M | ﹤0.01% | 1358 |
|
|
2021
Q2 | $8.85M | Buy |
92,768
+25,180
| +37% | +$2.4M | ﹤0.01% | 1212 |
|
|
2021
Q1 | $7.7M | Sell |
67,588
-26,318
| -28% | -$3M | ﹤0.01% | 1304 |
|
|
2020
Q4 | $13M | Buy |
93,906
+21,771
| +30% | +$3.01M | 0.01% | 1002 |
|
|
2020
Q3 | $5.93M | Sell |
72,135
-21,775
| -23% | -$1.79M | ﹤0.01% | 1215 |
|
|
2020
Q2 | $7.35M | Sell |
93,910
-66,328
| -41% | -$5.19M | 0.01% | 1117 |
|
|
2020
Q1 | $7.12M | Buy |
160,238
+26,869
| +20% | +$1.19M | 0.01% | 1038 |
|
|
2019
Q4 | $5.7M | Buy |
133,369
+43,865
| +49% | +$1.87M | ﹤0.01% | 1347 |
|
|
2019
Q3 | $3.83M | Buy |
89,504
+44,777
| +100% | +$1.92M | ﹤0.01% | 1513 |
|
|
2019
Q2 | $2.84M | Buy |
44,727
+3,437
| +8% | +$218K | ﹤0.01% | 1702 |
|
|
2019
Q1 | $2.86M | Buy |
41,290
+2,075
| +5% | +$144K | ﹤0.01% | 1671 |
|
|
2018
Q4 | $1.71M | Sell |
39,215
-158
| -0.4% | -$6.87K | ﹤0.01% | 1907 |
|
|
2018
Q3 | $3.01M | Sell |
39,373
-14,033
| -26% | -$1.07M | ﹤0.01% | 1691 |
|
|
2018
Q2 | $4.1M | Sell |
53,406
-4,441
| -8% | -$341K | ﹤0.01% | 1563 |
|
|
2018
Q1 | $2.95M | Buy |
57,847
+7,457
| +15% | +$380K | ﹤0.01% | 1780 |
|
|
2017
Q4 | $2.34M | Sell |
50,390
-77,633
| -61% | -$3.6M | ﹤0.01% | 1906 |
|
|
2017
Q3 | $6.82M | Buy |
128,023
+1,610
| +1% | +$85.8K | 0.01% | 1235 |
|
|
2017
Q2 | $7.85M | Sell |
126,413
-18,029
| -12% | -$1.12M | 0.01% | 1131 |
|
|
2017
Q1 | $9.79M | Buy |
144,442
+26,502
| +22% | +$1.8M | 0.01% | 1063 |
|
|
2016
Q4 | $8.29M | Sell |
117,940
-1,436
| -1% | -$101K | 0.01% | 1125 |
|
|
2016
Q3 | $8.47M | Sell |
119,376
-21,811
| -15% | -$1.55M | 0.01% | 1141 |
|
|
2016
Q2 | $6.91M | Buy |
141,187
+56,038
| +66% | +$2.74M | 0.01% | 1252 |
|
|
2016
Q1 | $5.39M | Buy |
85,149
+28,705
| +51% | +$1.82M | 0.01% | 1321 |
|
|
2015
Q4 | $6.33M | Buy |
56,444
+2,147
| +4% | +$241K | 0.01% | 1312 |
|
|
2015
Q3 | $5.23M | Buy |
54,297
+2,120
| +4% | +$204K | 0.01% | 1432 |
|
|
2015
Q2 | $5.34M | Buy |
52,177
+18,500
| +55% | +$1.89M | 0.01% | 1528 |
|
|
2015
Q1 | $2.09M | Buy |
33,677
+13,412
| +66% | +$833K | ﹤0.01% | 2133 |
|
|
2014
Q4 | $889K | Buy |
20,265
+8,913
| +79% | +$391K | ﹤0.01% | 2901 |
|
|
2014
Q3 | $642K | Buy |
+11,352
| New | +$642K | ﹤0.01% | 3064 |
|